India’s Granules makes $22M play for Senn Chemicals to enter peptides CDMO business
Granules shelled out a reported 20 million Swiss francs ($22.3 million) to acquire Swiss CDMO Senn Chemicals. The move positions the Hyderabad, India-based drug manufacturer to enter the booming peptides production business being driven by innovative weight-loss drugs.
Granules shelled out a reported 20 million Swiss francs ($22.3 million) to acquire Swiss CDMO Senn Chemicals. The move positions the Hyderabad, India-based drug manufacturer to enter the booming peptides production business being driven by innovative weight-loss drugs.
